List of Tables
Table 1. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Hepatitis B Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Hepatitis B Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Hepatitis B Vaccines Sales (M Doses) of Key Manufacturers (2019-2024)
Table 5. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Hepatitis B Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
Table 18. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Hepatitis B Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 27. North America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 28. North America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 32. Europe Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 33. Europe Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Hepatitis B Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
Table 37. Asia Pacific Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
Table 38. Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 42. Latin America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 43. Latin America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
Table 47. Middle East & Africa Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
Table 48. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Hepatitis B Vaccines Sales (M Doses) by Type (2019-2024)
Table 51. Global Hepatitis B Vaccines Sales (M Doses) by Type (2025-2030)
Table 52. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Hepatitis B Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Hepatitis B Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2024)
Table 59. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2025-2030)
Table 60. Global Hepatitis B Vaccines Sales (M Doses) by Application (2019-2024)
Table 61. Global Hepatitis B Vaccines Sales (M Doses) by Application (2025-2030)
Table 62. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Hepatitis B Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Hepatitis B Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2024)
Table 69. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2025-2030)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 73. GSK Hepatitis B Vaccines Product
Table 74. GSK Recent Developments/Updates
Table 75. NCPC Corporation Information
Table 76. NCPC Description and Business Overview
Table 77. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 78. NCPC Hepatitis B Vaccines Product
Table 79. NCPC Recent Developments/Updates
Table 80. Merck Corporation Information
Table 81. Merck Description and Business Overview
Table 82. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 83. Merck Hepatitis B Vaccines Product
Table 84. Merck Recent Developments/Updates
Table 85. Bio Kangtai Corporation Information
Table 86. Bio Kangtai Description and Business Overview
Table 87. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 88. Bio Kangtai Hepatitis B Vaccines Product
Table 89. Bio Kangtai Recent Developments/Updates
Table 90. Dynavax Corporation Information
Table 91. Dynavax Description and Business Overview
Table 92. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 93. Dynavax Hepatitis B Vaccines Product
Table 94. Dynavax Recent Developments/Updates
Table 95. Hissen Corporation Information
Table 96. Hissen Description and Business Overview
Table 97. Hissen Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 98. Hissen Hepatitis B Vaccines Product
Table 99. Hissen Recent Developments/Updates
Table 100. KM Biologics Corporation Information
Table 101. KM Biologics Description and Business Overview
Table 102. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 103. KM Biologics Hepatitis B Vaccines Product
Table 104. KM Biologics Recent Developments/Updates
Table 105. LG Life Sciences Corporation Information
Table 106. LG Life Sciences Description and Business Overview
Table 107. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 108. LG Life Sciences Hepatitis B Vaccines Product
Table 109. LG Life Sciences Recent Developments/Updates
Table 110. Serum Institute Corporation Information
Table 111. Serum Institute Description and Business Overview
Table 112. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
Table 113. Serum Institute Hepatitis B Vaccines Product
Table 114. Serum Institute Recent Developments/Updates
Table 115. Key Raw Materials Lists
Table 116. Raw Materials Key Suppliers Lists
Table 117. Hepatitis B Vaccines Distributors List
Table 118. Hepatitis B Vaccines Customers List
Table 119. Hepatitis B Vaccines Market Trends
Table 120. Hepatitis B Vaccines Market Drivers
Table 121. Hepatitis B Vaccines Market Challenges
Table 122. Hepatitis B Vaccines Market Restraints
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hepatitis B Vaccines
Figure 2. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Hepatitis B Vaccines Market Share by Type in 2023 & 2030
Figure 4. Yeast Derived Product Picture
Figure 5. CHO Derived Product Picture
Figure 6. Global Hepatitis B Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hepatitis B Vaccines Market Share by Application in 2023 & 2030
Figure 8. Children
Figure 9. Adult
Figure 10. Global Hepatitis B Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Hepatitis B Vaccines Market Size (2019-2030) & (US$ Million)
Figure 12. Global Hepatitis B Vaccines Sales (2019-2030) & (M Doses)
Figure 13. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2019-2030)
Figure 14. Hepatitis B Vaccines Report Years Considered
Figure 15. Hepatitis B Vaccines Sales Share by Manufacturers in 2023
Figure 16. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2023
Figure 17. The Global 5 and 10 Largest Hepatitis B Vaccines Players: Market Share by Revenue in 2023
Figure 18. Hepatitis B Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 19. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 20. North America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 21. North America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 22. U.S. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 23. Canada Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Europe Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 25. Europe Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 26. Germany Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. France Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. U.K. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. Italy Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Russia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2019-2030)
Figure 32. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2019-2030)
Figure 33. China Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Japan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. South Korea Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. India Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Australia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Taiwan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Indonesia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Thailand Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Malaysia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Philippines Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Latin America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 44. Latin America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 45. Mexico Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Brazil Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Argentina Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Middle East & Africa Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
Figure 49. Middle East & Africa Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
Figure 50. Turkey Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Saudi Arabia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. UAE Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Global Sales Market Share of Hepatitis B Vaccines by Type (2019-2030)
Figure 54. Global Revenue Market Share of Hepatitis B Vaccines by Type (2019-2030)
Figure 55. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2030)
Figure 56. Global Sales Market Share of Hepatitis B Vaccines by Application (2019-2030)
Figure 57. Global Revenue Market Share of Hepatitis B Vaccines by Application (2019-2030)
Figure 58. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2030)
Figure 59. Hepatitis B Vaccines Value Chain
Figure 60. Hepatitis B Vaccines Production Process
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Distributors Profiles
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed